Functional neuroimaging may indicate self-reported psychotic symptoms in adolescence

A group of researchers measured functional imaging responses to stop-signal, monetary incentive delay and face tasks to investigate the neural correlates of psychotic-like experiences in youth. Participants were tested to see whether these neurofunctional correlates of risk would be used to predict psychotic symptoms two years later.

“Studying young adolescents prone to [psychotic-like experiences] will help to identify etiologic processes implicated in psychosis proneness, without the confounds of diverse risk factors and iatrogenic effects, such as substance misuse, medication, and social impairment,” wrote the authors.  

In the study, which published in The American Journal of Psychiatry, researchers collected functional imaging responses from a group of 14-year-olds. At baseline, youths were assessed on psychotic-like experiences. If they reported any significant experiences, they were compared to matched control subjects. Significant brain activity differences between the groups were used to predict, with cross-validation, if there were any psychotic symptoms in the context of mood fluctuation at age 16.

Researchers found that the most significant regional difference between participants with mood fluctuation and psychotic symptoms and the control groups were hyperactivation of the hippocampus/amygdala, when controlling for baseline psychotic-like experiences and cannabis use. 

“Relative to control subjects, youths reporting psychotic-like experiences showed increased hippocampus/amygdala activity during processing of neutral faces and reduced dorsolateral prefrontal activity during failed inhibition,” wrote the authors.

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.